Skip to main content


Figure 5 | Molecular Cancer

Figure 5

From: Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway

Figure 5

BHX inhibits A549 cell tumorigenesis in a xenograft model. Tumor-bearing mice were treated intraperitoneally with vehicle (DMSO) or BHX (25 and 50 mg/kg) daily for 21 d. Tumor size (A), tumor weight (B), and body weight (C) were measured as described in the Materials and methods section. Data are presented as mean ± SD. *P < 0.05, **P < 0.01, significant relative to vehicle control.

Back to article page